drugset / Trial / NCT00209469
Network Osteoporosis Study
Phase 2/3
Unknown
90 enrolled
Glaser Pediatric Research Network
Elizabeth Glaser Pediatric AIDS Foundation · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is evaluating the use of the drug alendronate in preventing or reversing bone loss in children and adolescents receiving steroid medications.
Timeline
- Start
- 2002-07
- Primary completion
- —
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alendronic Acid | Small molecule | — | — |